(Q33289528)

25 July 2017

title

Invasive meningococcal disease epidemiology and control measures: a framework for evaluation (English)

1 reference

25 July 2017

main subject

meningococcal disease

1 reference

1

J Jaime Caro

1 reference

25 July 2017

Jörgen Möller

2

1 reference

25 July 2017

Denis Getsios

3

1 reference

25 July 2017

L Coudeville

4

1 reference

25 July 2017

Wissam El-Hadi

5

1 reference

25 July 2017

Catherine Chevat

6

1 reference

25 July 2017

Van Hung Nguyen

7

1 reference

25 July 2017

Ingrid Caro

8

1 reference

25 July 2017

language of work or name

English

0 references

publication date

29 June 2007

1 reference

25 July 2017

1 reference

25 July 2017

volume

7

1 reference

25 July 2017

page(s)

130

1 reference

Creative Commons Attribution 2.0 Generic

25 July 2017

copyright license

start time

29 June 2007

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1471-2458-7-130

0 references

cites work

Reassessing the cost-effectiveness of meningococcal serogroup C conjugate (MCC) vaccines using a transmission dynamic model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1925079

Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP)

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1925079

Economic evaluation of meningococcal serogroup C conjugate vaccination programmes in The Netherlands and its impact on decision-making.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1925079

Assessing the economics of vaccination for Neisseria meningitidis in industrialized nations: a review and recommendations for further research

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1925079

Neisseria meningitidis: an overview of the carriage state

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1925079

Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1925079

Diversity in pathogenicity can cause outbreaks of meningococcal disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1925079

Meningococcal conjugate vaccines.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1925079

Predicting meningococcal disease outbreaks in structured populations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1925079

Modeling infection transmission

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1925079

Epidemiology of meningococcal disease, New York City, 1989-2000.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1925079

Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1925079

A model for a smallpox-vaccination policy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1925079

Meningococcal infections in children from Arkansas

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1925079

Influence of serogroup on the presentation, course, and outcome of invasive meningococcal disease in children in the Republic of Ireland, 1995-2000.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1925079

Health economics of a hexavalent meningococcal outer-membrane vesicle vaccine in children: potential impact of introduction in the Dutch vaccination program

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1925079

21 June 2018

Meningococcal disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1925079

School-based clusters of meningococcal disease in the United States. Descriptive epidemiology and a case-control analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1925079

Impact of a mass immunization campaign against serogroup C meningococcus in the Province of Quebec, Canada.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1925079

Complications and sequelae of meningococcal disease in Quebec, Canada, 1990-1994.

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-7-130

Complications of meningococcal disease in college students.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-7-130

Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-7-130

Invasive meningococcal and pneumococcal disease in Switzerland: cost?utility analysis of different vaccine strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-7-130

Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-7-130

Pharmacoeconomic analyses using discrete event simulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-7-130

The EQ-5D and the Health Utilities Index for permanent sequelae after meningitis: a head-to-head comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-7-130

Mathematical modelling of infection and disease due to Neisseria meningitidis and Neisseria lactamica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-7-130

A mathematical model for evaluating the impact of vaccination schedules: application to Neisseria meningitidis

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1925079

A retrospective survey of clusters of meningococcal disease in England and Wales, 1993 to 1995: estimated risks of further cases in household and educational settings.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1925079

Neisseria meningitidis Carriage during an Outbreak of Serogroup C Disease

31 October 2018

1 reference

12 December 2020

Genotype-specific carriage of Neisseria meningitidis in Georgia counties with hyper- and hyposporadic rates of meningococcal disease

1 reference

12 December 2020

Vaccinating first-year college students living in dormitories for Meningococcal disease: an economic analysis

1 reference

12 December 2020

Meningococcal serogroup C conjugate vaccination in England and Wales: coverage and initial impact of the campaign

1 reference

12 December 2020

Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States

1 reference

12 December 2020

Epidemiology of meningococcal disease in Switzerland, 1999-2002

1 reference

12 December 2020

Should college students be vaccinated against meningococcal disease? A cost-benefit analysis

1 reference

12 December 2020

Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Control and prevention of serogroup C meningococcal disease: evaluation and management of suspected outbreaks: recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

12 December 2020

Relative efficacy of different immunization schedules for the prevention of serogroup C meningococcal disease: a model-based evaluation

1 reference

12 December 2020

The Changing Epidemiology of Meningococcal Disease in the United States, 1992–1996

1 reference

12 December 2020

Meningococcal disease and college students. Recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

12 December 2020

Invasive meningococcal disease in Canada, 1 January 1997 to 31 December 1998

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2458-7-130

1 reference

Dimensions Publication ID

25 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2458-7-130

9 September 2019

1 reference

25 July 2017

1 reference